12881_2017_509_MOESM2_ESM.docx (14.61 kB)
Additional file 2: Table S2. of The gene–treatment interaction of paraoxonase-1 gene polymorphism and statin therapy on insulin secretion in Japanese patients with type 2 diabetes: Fukuoka diabetes registry
journal contribution
posted on 2017-12-12, 05:00 authored by Akiko Sumi, Udai Nakamura, Masanori Iwase, Hiroki Fujii, Toshiaki Ohkuma, Hitoshi Ide, Tamaki Jodai-Kitamura, Yuji Komorita, Masahito Yoshinari, Yoichiro Hirakawa, Atsushi Hirano, Michiaki Kubo, Takanari KitazonoClinical characteristics according to PON1 genotype. Data are expressed as mean ± SD, median (interquartile), and n (percentage). CVD: cardiovascular disease, OHA: oral hypoglycemic agents, α-GI: alpha-glucosidase inhibitor, DPP4-I: inhibitors of type 4 dipeptidyl peptidase* log-transformed for the statistical analysis. (DOCX 14 kb)
